| Literature DB >> 34831097 |
Naghmeh Hadidi1, Niloufar Shahbahrami Moghadam2, Gholamreza Pazuki3, Parviz Parvin4, Fatemeh Shahi4.
Abstract
Nowadays, finding a novel, effective, biocompatible, and minimally invasive cancer treatment is of great importance. One of the most promising research fields is the development of biocompatible photothermal nanocarriers. PTT (photothermal therapy) with an NIR (near-infrared) wavelength range (700-2000 nm) would cause cell death by increasing intercellular and intracellular temperature. PTT could also be helpful to overcome drug resistance during cancer treatments. In this study, an amine derivative of phospholipid poly ethylene glycol (DSPE-PEG (5000) amine) was conjugated with SWCNTs (single-walled carbon nanotubes) to reduce their intrinsic toxicity. Toxicity studies were performed on lung, liver, and ovarian cancer cell lines that were reported to show some degree of drug resistance to cisplatin. Toxicity results suggested that DSPE-PEG (5000) amine SWCNTs might be biocompatible photothermal nanocarriers in PTT. Therefore, our next step was to investigate the effect of DSPE-PEG (5000) amine SWCNT concentration, cell treatment time, and laser fluence on the apoptosis/necrosis of SKOV3 cells post-NIR exposure by RSM and experimental design software. It was concluded that photothermal efficacy and total apoptosis would be dose-dependent in terms of DSPE-PEG (5000) amine SWCNT concentration and fluence. Optimal solutions which showed the highest apoptosis and lowest necrosis were then achieved.Entities:
Keywords: DSPE-PEG (5000) amine; SKOV3; SWCNT; experimental design; photothermal therapy; response surface methodology (RSM); toxicity
Mesh:
Substances:
Year: 2021 PMID: 34831097 PMCID: PMC8616160 DOI: 10.3390/cells10112874
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Variables for experimental design and response surface methodology (central composite).
|
|
|
|
|
|
|
| A | NIR exposure fluence (J/cm2) | 120–360 | In range | 1 | 3 |
| B | DSPE-PEG 5000-NH2-SWCNT (μg/mL) | 2.5–25 | In range | 1 | 3 |
| C | Cell Treatment Time (hour) | 18, 24 | 24 | 1 | 3 |
| Response | |||||
| Y1 | Total Apoptosis (%) | 6.2–78.87 | Maximize (≥50%) | 1 | 3 |
| Y2 | Temperature change (∆T ≈ °C) | 0–19.75 | In range (10–15 °C) | 1 | 3 |
| Y3 | Post NIR exposure time (h) | 24, 48 | none | 1 | 3 |
| Y4 | Necrosis (%) | 1.52–12.53 | Minimize (≤8%) | 1 | 3 |
Figure 1TGA diagram of pure SWCNTs and DSPE-PEG (5000) amine SWCNTs.
Figure 2XRD patterns of pure SWCNTs and DSPE-PEG (5000) amine SWCNTs.
Roughness analysis of SWCNTs and DSPE-PEG (5000) amine SWCNTs by AFM (n = 3).
| Ra (pm) | Rq (pm) | Rt (nm) | |
|---|---|---|---|
| SWCNT | 1161 ± 7.82 | 2456 ± 1.29 | 48.99 ± 4.99 |
| DSPE-PEG 5000-NH2-SWCNT | 312.35 ± 6.65 | 455 ± 2.86 | 7.628 ± 2.23 |
Twenty-four and seventy-two hours IC50 (µg/mL) of HEPG2, A549, and SKOV3 cells after treatment with pure SWCNTs and DSPE-PEG (5000) amine SWNTs (n = 3).
| Cell Line | Samples | IC50 (µg/mL) after | |
|---|---|---|---|
| 24 h | 72 h | ||
| HEPG2 | Pure SWCNT | 150 ± 6.35 | 50 ± 7.50 |
| A549 | Pure SWCNT | 150 ± 7.6 | 50 ± 4.95 |
| SKOV3 | Pure SWCNT | 150 ± 7.56 | 50 ± 4.8 |
Experimental runs designed by RSM (central composite design).
| Independent Variables | Responses | ||||||
|---|---|---|---|---|---|---|---|
| Run | A: DSPE-PEG5000-NH2-SWCNT Concentration (μg/mL) | B: NIR Exposure Fluence (J/cm2) | C: Cell Treatment Time (h) | Y1: Total Apoptosis (%) | Y2: ∆T (°C) | Y3: Post NIR Exposure (h) | Y4: Necrosis (%) |
| 1 | 2.5 | 120 | 18 | 36.65 ± 2.46 | 4 ± 2.86 | 24 | 5.93 ± 3.24 |
| 2 | 2.5 | 120 | 18 | 31.10 ± 2.41 | 4.4 ± 4.29 | 48 | 2.70 ± 1.12 |
| 3 | 2.5 | 120 | 24 | 18.13 ± 1.09 | 4 ± 1.73 | 24 | 7.11 ± 2.60 |
| 4 | 2.5 | 120 | 24 | 38.97 ± 1.31 | 0.65 ± 0.69 | 48 | 2.99 ± 1.06 |
| 5 | 0 | 120 | 18 | 24.92 ± 2.25 | 5.5 ± 5.05 | 24 | 5.08 ± 1.29 |
| 6 | 0 | 120 | 18 | 30.42 ± 2.16 | 3.6 ± 1.3 | 48 | 2.52 ± 1.21 |
| 7 | 0 | 120 | 24 | 20.47 ± 2.98 | 2.85 ± 1.05 | 24 | 6.80 ± 1.64 |
| 8 | 0 | 120 | 24 | 33.18 ± 1.68 | 2.26 ± 0.33 | 48 | 3.06 ± 1.67 |
| 9 | 25 | 120 | 18 | 51.93 ± 3.84 | 10.3 ± 0.49 | 24 | 11.58 ± 4.13 |
| 10 | 25 | 120 | 18 | 42.93 ± 2.14 | 6.73 ± 3.30 | 48 | 4.95 ± 0.17 |
| 11 | 25 | 120 | 24 | 28.44 ± 1.74 | 10.03 ± 0.46 | 24 | 1.52 ± 1.20 |
| 12 | 25 | 120 | 24 | 43.94 ± 1.85 | 8.9 ± 2.5 | 48 | 2.77 ± 1.72 |
| 13 | 2.5 | 0 | 18 | 37.03 ± 1.27 | 0 | 24 | 7.50 ± 0.92 |
| 14 | 2.5 | 0 | 18 | 30.88 ± 1.46 | 0 | 48 | 4.03 ± 1.75 |
| 15 | 2.5 | 0 | 24 | 32.63 ± 1.74 | 0 | 24 | 7.05 ± 3.45 |
| 16 | 2.5 | 0 | 24 | 36.59 ± 5.19 | 0 | 48 | 3.53 ± 1.86 |
| 17 | 25 | 0 | 18 | 44.04 ± 2.33 | 0 | 24 | 7.20 ± 1.97 |
| 18 | 25 | 0 | 18 | 35.02 ± 0.38 | 0 | 48 | 5.08 ± 1.75 |
| 19 | 25 | 0 | 24 | 36.63 ± 2.38 | 0 | 24 | 5.26 ± 1.61 |
| 20 | 25 | 0 | 24 | 46.12 ± 4.15 | 0 | 48 | 3.55 ± 1.16 |
| 21 | 13.75 | 0 | 18 | 50.43 ± 1.55 | 0 | 24 | 4.82 ± 3.58 |
| 22 | 13.75 | 0 | 18 | 38.98 ± 0.94 | 0 | 48 | 10.42 ± 1.38 |
| 23 | 13.75 | 0 | 24 | 37.69 ± 4.37 | 0 | 24 | 2.62 ± 1.89 |
| 24 | 13.75 | 0 | 24 | 46.64 ± 5.97 | 0 | 48 | 2.46 ± 1.02 |
| 25 | 13.75 | 240 | 18 | 61.54 ± 4.49 | 12.4 ± 1.49 | 24 | 7.43 ± 3.42 |
| 26 | 13.75 | 240 | 18 | 59.02 ± 3.27 | 14.13 ± 1.40 | 48 | 4.57 ± 1.79 |
| 27 | 13.75 | 240 | 24 | 46.45 ± 3.48 | 14.13 ± 2.46 | 24 | 6.74 ± 4.74 |
| 28 | 13.75 | 240 | 24 | 63.53 ± 5.36 | 9.68 ± 1.04 | 48 | 4.45 ± 2.41 |
| 29 | 0 | 240 | 18 | 42.30 ± 3.85 | 3.5 ± 1.30 | 24 | 6.43 ± 5.15 |
| 30 | 0 | 240 | 18 | 38.16 ± 2.84 | 6.43 ± 2.0 | 48 | 2.81 ± 0.42 |
| 31 | 0 | 240 | 24 | 22.84 ± 1.17 | 2.6 ± 0.7 | 24 | 8.00 ± 2.10 |
| 32 | 0 | 240 | 24 | 32.84 ± 2.72 | 3 ± 0.1 | 48 | 1.77 ± 0.95 |
| 33 | 2.5 | 360 | 18 | 43.23 ± 4.85 | 12.1 ± 4.95 | 24 | 6.56 ± 2.22 |
| 34 | 2.5 | 360 | 18 | 48.88 ± 3.24 | 7.42 ± 1.28 | 48 | 5.83 ± 3.41 |
| 35 | 2.5 | 360 | 24 | 45.68 ± 2.84 | 5.95 ± 1.39 | 24 | 6.59 ± 0.79 |
| 36 | 2.5 | 360 | 24 | 60.22 ± 3.33 | 5.74 ± 1.38 | 48 | 6.33 ± 1.31 |
| 37 | 0 | 360 | 18 | 37.85 ± 2.46 | 3.33 ± 1.32 | 24 | 5.03 ± 1.81 |
| 38 | 0 | 360 | 18 | 44.25 ± 2.83 | 6.76 ± 0.49 | 48 | 7.58 ± 1.53 |
| 39 | 0 | 360 | 24 | 31.97 ± 3.20 | 3.36 ± 0.23 | 24 | 4.81 ± 1.65 |
| 40 | 0 | 360 | 24 | 46.08 ± 5.17 | 3.76 ± 0.57 | 48 | 2.58 ± 0.80 |
| 41 | 25 | 360 | 18 | 78.87 ± 2.99 | 19.62 ± 1.8 | 24 | 11.46 ± 1.38 |
| 42 | 25 | 360 | 18 | 73.38 ± 2.25 | 12.87 ± 1.74 | 48 | 12.53 ± 3.91 |
| 43 | 25 | 360 | 24 | 61.43 ± 5.93 | 19.75 ± 1.24 | 24 | 3.22 ± 2.15 |
| 44 | 25 | 360 | 24 | 76.64 ± 2.60 | 16.07 ± 0.65 | 48 | 6.25 ± 1.22 |
| 45 | 0 | 0 | 18 | 18.95 ± 4.66 | 0 | 24 | 10.89 ± 4.75 |
| 46 | 0 | 0 | 18 | 8.52 ± 3.02 | 0 | 48 | 4.21 ± 2.13 |
| 47 | 0 | 0 | 24 | 6.20 ± 1.19 | 0 | 24 | 2.47 ± 2.16 |
| 48 | 0 | 0 | 24 | 18.98 ± 4.91 | 0 | 48 | 1.52 ± 1.37 |
Figure 3Contour plot of total apoptosis (Y1) in SKOV3 cells.
Figure 4Contour plot of temperature changes (∆T ≈ °C) (Y2) in SKOV3 cells.
Figure 5Flow cytometry analysis of SKOV3 cells, 24 h post-NIR exposure: (A) DSPE-PEG (5000) amine SWCNTs (25 μg/mL) with NIR exposure fluence (360 J/cm2), (B) DSPE-PEG (5000) amine SWCNTs (0 μg/mL) with NIR exposure fluence (360 J/cm2), (C) DSPE-PEG (5000) amine SWCNTs (25 μg/mL) without NIR exposure, (D) DSPE-PEG (5000) amine SWCNTs (0 μg/mL) without NIR exposure fluence (negative control), (E) GNRs (25 μg/mL) with NIR exposure fluence (360 J/cm2) (positive control), and (F) unstained sample.
Figure 6Overlay plot of optimal results (Red points show some of the experiments included in design algorithm).